DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Cameron D, Piccart-Gebhart MJ, Gelber RD. et al.
11 yearsʼ follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.

Lancet 2017;
389: 1195-1205

Download Bibliographical Data

Search in:
Access: